Q4 2018 Holdings
Filed 2019-02-14 | 70 holdings | $77.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argen SE(ARGX) | SPONSORED ADR | 04016X101 | $43.2M | 450,000 | 55.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $21.2M | 338,456 | 27.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.5M | 296,712 | 5.8% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $4.2M | 245,370 | 5.4% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.5M | 478,055 | 4.5% |
| Tesaro IncCall | COM | 881569107 | $93.1K | 1,253,300 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $74.3K | 1,751,699 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $70.5K | 1,105,557 | 0.1% |
| Tesaro Inc | COM | 881569107 | $66.8K | 900,000 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $59.4K | 4,502,498 | 0.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $53.7K | 1,475,140 | 0.1% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $40.4K | 1,474,362 | 0.1% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $37.8K | 674,251 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $37.2K | 3,481,471 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $33.6K | 1,422,911 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $33.1K | 677,451 | 0.0% |
| Quotient LTD | SHS | G73268107 | $29.1K | 4,762,772 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $28.8K | 1,945,659 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $24.0K | 650,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $23.3K | 831,000 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $22.6K | 884,916 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $22.6K | 1,357,784 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $19.5K | 361,351 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $19.4K | 1,285,828 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $19.0K | 994,287 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $18.6K | 511,395 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $18.3K | 787,426 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $18.0K | 547,000 | 0.0% |
| Sage Therapeutics Inc(SG7)Put | COM | 78667J108 | $17.6K | 184,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $17.6K | 183,732 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $17.5K | 652,987 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $17.3K | 731,621 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $16.3K | 706,064 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $16.0K | 251,335 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $15.6K | 218,222 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $12.3K | 290,239 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $11.7K | 300,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.8K | 90,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $9.5K | 700,000 | 0.0% |
| Zogenix IncCall | COM NEW | 98978L204 | $9.1K | 250,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $8.3K | 580,756 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $8.2K | 250,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $8.0K | 441,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $7.8K | 150,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.7K | 550,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $5.9K | 375,000 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $5.8K | 360,910 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $5.3K | 385,846 | 0.0% |
| Constellation Pharmaceuticals I(CNST) | COM | 210373106 | $5.1K | 1,271,687 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $4.8K | 210,078 | 0.0% |